Conditions: Healthy
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 6
Healthy volunteers: yes

Brief summary:
The aim of this study is to assess the mass balance recovery from excreta of carbon 14 labelled BI409306 (\[14C\] BI 409306) in healthy, CYP2C19 genotyped subjects and to provide plasma, urine and faecal samples for metabolite profiling and structural identification.

Detailed description:

Arms:
arm 1: 14C-BI 409306 oral solution

Interventions: intervention 1: 14C-BI 409306
Intervention descriptions: intervention 1: None

Protocol document: